Guided Therapeutics (GTHP) Cash from Operations (QoQ) (2017 - 2025)
Guided Therapeutics (GTHP) Cash from Operations (QoQ) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Guided Therapeutics | 21.96 Mn | 21.89 Mn | 458,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -5.05% |
| Sep 30, 2025 | -63.91% |
| Jun 30, 2025 | 48.94% |
| Mar 31, 2025 | 0.30% |
| Dec 31, 2024 | 29.81% |
| Sep 30, 2024 | -121.03% |
| Jun 30, 2024 | -114.00% |
| Mar 31, 2024 | 70.24% |
| Dec 31, 2023 | 28.96% |
| Sep 30, 2023 | -7.99% |
| Jun 30, 2023 | 12.22% |
| Mar 31, 2023 | -47.20% |
| Dec 31, 2022 | 44.61% |
| Sep 30, 2022 | -75.36% |
| Jun 30, 2022 | -94.97% |
| Mar 31, 2022 | -212.58% |
| Dec 31, 2021 | 121.52% |
| Sep 30, 2021 | -6.79% |
| Jun 30, 2021 | -116.25% |
| Mar 31, 2021 | 3.32% |